Audited Financial Results for the quarter and year ended March 31, 2026
PRSMJOHNSN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250 and 0.4 pts less than its Cement & Cement Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Prism Johnson Limited reported standalone net sales of ₹7,254 Cr for FY26, up 8.3% YoY from ₹6,697 Cr. Net profit after tax fell to ₹55.99 Cr from ₹102.19 Cr — a steep 45% decline — despite improved operating margins (8.98% vs 5.94% YoY) driven by cost efficiencies and higher other income. The Q4 standalone result showed a net loss of ₹47.96 Cr due to a ₹79.03 Cr impairment on the Raheja QBE subsidiary investment (classified as held for sale pending regulatory approval). Exceptional items include a ₹151.46 Cr gain from office premises sale and a ₹149.19 Cr gain from Pen plant sale. The company has debt of ₹955.70 Cr with a debt-equity ratio of 0.62x, within comfortable limits. Statutory auditors SRBC&Co. LLP issued an unmodified opinion on both standalone and consolidated results.
PAT decline of 45% YoY is a concern, though much of it stems from one-time impairment charges. The core business showed margin expansion and revenue growth, but the Q4 loss and the ongoing divestment of the insurance subsidiary signal a period of restructuring that investors should monitor closely.